Carrier Financially Commits to Cold Chain Offshoot, Ember LifeSciences
Investment helps encourage sustainability in the space, especially as it pertains to pharma, company says.
Carrier Global Corporation, a cold chain solutions provider, is investing in Ember LifeSciences, creator of the Ember Cube. Launched last year as a healthcare-focused spinoff of Ember Technologies, Inc., Ember LifeSciences aims to improve patient outcomes and encourage reusability in the temperature control technology sector.
As previously reported by Pharma Commerce, the Ember Cube is a cloud-based shipping box that features a refrigeration system to help ensure the safety of temperature-sensitive biologics while in transit, sending location, temperature, and humidity levels to the cloud. More specifically, notes Carrier, the branded product offers a sustainable alternative, and with the help of technology—including a return-to-sender feature—it is able to address the pounds of annual packaging waste from the pharma cold chain that result from single-use shipping materials such as cardboard, expanded polystyrene foam (often known as Styrofoam), and ice packs.
"Logistics failures within the biopharma industry result in roughly $35 billion worth of pharmaceutical products not reaching the people who need them," says Jennifer Anderson, SVP of strategy and business development, and chief sustainability officer for Carrier. “… Together, we can continue to advance the connected cold chain, build upon our lynx digital platform, and further strengthen Carrier's position in this space."
